Squamous cell carcinoma
MONDO:0005096A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.
Also known as: carcinoma, squamous cell, malignant, epidermoid carcinoma, epidermoid cell cancer, malignant epidermoid cell neoplasm, malignant epidermoid cell tumor, malignant epidermoid cell tumour, malignant squamous cell neoplasm, malignant squamous cell tumor
4392 clinical trials for this condition and its sub-types, 177 tagged with Squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Squamous cell carcinoma
-
Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types
13 sub-types
- Pharyngeal squamous cell carcinoma 5 trials · 203 incl. sub-types Sub-types →
- Lip and oral cavity squamous cell carcinoma 21 trials · 157 incl. sub-types Sub-types →
- Laryngeal squamous cell carcinoma 72 trials · 77 incl. sub-types Sub-types →
- Nasal cavity and paranasal sinus squamous cell carcinoma 9 trials · 13 incl. sub-types Sub-types →
- Nasopharyngeal squamous cell carcinoma 12 trials
- Paranasal sinus squamous cell carcinoma 11 trials Sub-types →
- Nasal cavity squamous cell carcinoma 6 trials
- External ear squamous cell carcinoma 1 trial
- Conjunctival squamous cell carcinoma 0 trials
- Cornea squamous cell carcinoma 0 trials
- Lacrimal gland squamous cell carcinoma 0 trials
- Middle ear squamous cell carcinoma 0 trials
- Primary intraosseous squamous cell carcinoma 0 trials
-
Esophageal squamous cell carcinoma 303 trials · 304 incl. sub-types
4 sub-types
- Esophageal adenosquamous carcinoma 3 trials
- Undifferentiated carcinoma of esophagus 1 trial
- Esophageal basaloid carcinoma 0 trials
- Esophagus verrucous carcinoma 0 trials
-
Skin squamous cell carcinoma 149 trials · 156 incl. sub-types
9 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Anal margin squamous cell carcinoma 4 trials
- Acantholytic squamous cell skin carcinoma 1 trial
- Clear cell squamous cell skin carcinoma 1 trial
- Sarcomatoid squamous cell skin carcinoma 1 trial
- Plantar verrucous skin carcinoma 0 trials
- Pseudovascular skin squamous cell carcinoma 0 trials
- Skin adenosquamous carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
-
Squamous cell lung carcinoma 65 trials · 145 incl. sub-types
2 sub-types
- Non-small cell squamous lung carcinoma 83 trials · 88 incl. sub-types Sub-types →
- Lung occult squamous cell carcinoma 0 trials
-
Human papillomavirus-related squamous cell carcinoma 115 trials · 116 incl. sub-types
1 sub-type
-
Colorectal squamous cell carcinoma 1 trial · 54 incl. sub-types
3 sub-types
- Squamous cell carcinoma of rectum 8 trials · 53 incl. sub-types Sub-types →
- Colorectal adenosquamous carcinoma 0 trials Sub-types →
- Squamous cell carcinoma of colon 0 trials Sub-types →
-
Adenosquamous carcinoma 8 trials · 45 incl. sub-types
15 sub-types
- Cervical adenosquamous carcinoma 16 trials Sub-types →
- Pancreatic adenosquamous carcinoma 13 trials
- Adenosquamous lung carcinoma 5 trials
- Esophageal adenosquamous carcinoma 3 trials
- Endometrial adenosquamous carcinoma 2 trials
- Bartholin gland adenosquamous carcinoma 0 trials
- Adenosquamous breast carcinoma 0 trials
- Adenosquamous prostate carcinoma 0 trials
- Colorectal adenosquamous carcinoma 0 trials Sub-types →
- Gallbladder adenosquamous carcinoma 0 trials
- Gastric adenosquamous carcinoma 0 trials
- Liver adenosquamous carcinoma 0 trials Sub-types →
- Salivary gland adenosquamous carcinoma 0 trials
- Skin adenosquamous carcinoma 0 trials
- Thymic adenosquamous carcinoma 0 trials
-
Cervical squamous cell carcinoma 36 trials · 40 incl. sub-types
7 sub-types
- Cervical adenosquamous carcinoma 16 trials Sub-types →
- Cervical basaloid carcinoma 0 trials
- Cervical keratinizing squamous cell carcinoma 0 trials
- Cervical lymphoepithelioma-like carcinoma 0 trials
- Cervical non-keratinizing squamous cell carcinoma 0 trials
- Cervical verrucous carcinoma 0 trials
- Microinvasive cervical squamous cell carcinoma 0 trials
-
Metastatic squamous cell carcinoma 39 trials
-
Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types
5 sub-types
-
Vulvar squamous cell carcinoma 22 trials
6 sub-types
- Bartholin gland squamous cell carcinoma 0 trials Sub-types →
- Vulva verrucous carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
- Vulvar keratoacanthoma-like carcinoma 0 trials
- Vulvar non-keratinizing squamous cell carcinoma 0 trials
-
Squamous cell carcinoma of pancreas 3 trials · 13 incl. sub-types
1 sub-type
- Pancreatic adenosquamous carcinoma 13 trials
-
Bone squamous cell carcinoma 0 trials · 11 incl. sub-types
1 sub-type
-
Squamous carcinoma in situ 5 trials · 10 incl. sub-types
3 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Penis carcinoma in situ 1 trial
- Trachea carcinoma in situ 0 trials
-
Vaginal squamous cell carcinoma 8 trials
-
Bladder squamous cell carcinoma 5 trials
2 sub-types
- Bladder urachal squamous cell carcinoma 0 trials
- Bladder verrucous carcinoma 0 trials
-
Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types
7 sub-types
- Anus basaloid carcinoma 3 trials
- Basaloid carcinoma of the penis 0 trials
- Cervical basaloid carcinoma 0 trials
- Esophageal basaloid carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
- Thymic basaloid carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
-
Gastric squamous cell carcinoma 4 trials
1 sub-type
- Gastric adenosquamous carcinoma 0 trials
-
Papillary squamous carcinoma 1 trial · 4 incl. sub-types
2 sub-types
- Verrucous carcinoma 0 trials · 3 incl. sub-types Sub-types →
- Papillary carcinoma of the penis 0 trials Sub-types →
-
Ovarian squamous cell carcinoma 2 trials
-
Urethra squamous cell carcinoma 2 trials
1 sub-type
- Urethral verrucous carcinoma 0 trials
-
Endometrial squamous cell carcinoma 0 trials · 2 incl. sub-types
1 sub-type
- Endometrial adenosquamous carcinoma 2 trials
-
Scrotum squamous cell carcinoma 1 trial
-
1 sub-type
-
Ureter squamous cell carcinoma 1 trial
-
Keratinizing squamous cell carcinoma 0 trials · 1 incl. sub-types
8 sub-types
- Acantholytic squamous cell skin carcinoma 1 trial
- Clear cell squamous cell skin carcinoma 1 trial
- Sarcomatoid squamous cell skin carcinoma 1 trial
- Cervical keratinizing squamous cell carcinoma 0 trials
- Large cell keratinizing variant squamous cell breast carcinoma 0 trials
- Pseudovascular skin squamous cell carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
-
Gallbladder squamous cell carcinoma 0 trials
1 sub-type
- Gallbladder adenosquamous carcinoma 0 trials
-
Prostate squamous cell carcinoma 0 trials
1 sub-type
- Adenosquamous prostate carcinoma 0 trials
-
Renal pelvis squamous cell carcinoma 0 trials
-
Sarcomatoid squamous cell carcinoma 0 trials
2 sub-types
-
Squamous cell breast carcinoma 0 trials
4 sub-types
-
2 sub-types
- Liver adenosquamous carcinoma 0 trials Sub-types →
- Squamous cell bile duct carcinoma 0 trials Sub-types →
-
Thymus squamous cell carcinoma 0 trials
2 sub-types
- Thymic adenosquamous carcinoma 0 trials
- Thymic basaloid carcinoma 0 trials
-
Trachea squamous cell carcinoma 0 trials
1 sub-type
- Trachea carcinoma in situ 0 trials
Most studied deeper sub-types
-
Lab-Grown immune cells take on head and neck cancer
Disease control CompletedThis early-phase trial tests a new approach for advanced head and neck cancer that has stopped responding to standard treatments. Doctors take a patient's own tumor-fighting immune cells (TILs), grow more of them in a lab, and give them back along with the immunotherapy drug Keyt…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy combo shows promise in Tough-to-Treat anal cancer
Disease control CompletedThis Phase 3 trial tested whether adding the immunotherapy drug retifanlimab to standard chemotherapy (carboplatin and paclitaxel) helps people with advanced anal cancer that cannot be removed by surgery. The study enrolled 308 adults who had not received chemotherapy for their a…
Phase 3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a shorter radiation course tame side effects in head and neck cancer?
Disease control CompletedThis trial is testing two different ways of delivering a second course of radiation to people whose head or neck cancer has come back after prior radiation. One approach uses a single daily dose of radiation combined with two chemotherapy drugs given every other week over 11 week…
Phase 2/3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can targeted radiation boost Immunotherapy's power against head and neck cancer?
Disease control CompletedThis trial is testing whether adding targeted radiation (SBRT) to two immunotherapy drugs, durvalumab and tremelimumab, can better control metastatic head and neck cancer. The study includes adults with this cancer that has spread, and the radiation is given between cycles of the…
Phase 1/2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New gel could speed healing after skin cancer surgery on face and neck
Disease control CompletedThis study tests whether a gel containing a human growth factor (rhPDGF-BB) can help wounds heal faster after skin cancer removal on the head or neck. About 40 adults whose surgical wounds are too large to stitch closed will receive either the gel or a placebo. The goal is to see…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could less radiation be enough after robotic throat cancer surgery?
Disease control CompletedThis study looks at whether giving lower doses of radiation to a smaller area after robotic surgery can still keep HPV-positive throat cancer from coming back. About 150 adults with early-stage throat cancer will receive this gentler radiation plan. The goal is to see if two year…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Drug combo aims to stall head and neck Cancer's return
Disease control CompletedThis phase 2 trial investigates whether combining two drugs—RAD001 (everolimus) and erlotinib (Tarceva)—can help control recurrent squamous cell carcinoma of the head and neck. The study enrolls adults whose cancer has returned after platinum-based chemotherapy. Participants take…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental drug aims to supercharge immune system before cancer surgery
Disease control CompletedThis early-phase study tested a single dose of an experimental antibody (MEDI0562) given before surgery to 13 patients with advanced head and neck cancer or melanoma. The goal was to see if the drug safely activates the immune system to fight the cancer. Researchers compared givi…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise in head and neck cancer trial
Disease control CompletedThis early-stage trial tested the safety of adding olaparib to standard chemotherapy and radiation for people with advanced head and neck cancer. Sixteen patients took part to find the best dose and see how well they tolerated the combination. The goal was to control the disease,…
Phase 1 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo therapy shows promise for incurable head and neck cancer
Disease control CompletedThis study looked at whether adding cetuximab to avelumab works better than avelumab alone for people with advanced head and neck cancer that has come back or spread. The cancer in these patients is not curable, and average survival is less than a year. The trial first checked th…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Lung cancer trial matches drugs to genes: a step toward personalized treatment
Disease control CompletedThis trial tested several targeted drugs in people with non-small cell lung cancer whose tumors had specific genetic changes. The goal was to see if these drugs could shrink tumors or delay cancer growth. Over 400 participants received treatment based on their tumor's genetic pro…
Phase 2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New graft promises better healing after skin cancer removal
Disease control CompletedThis study tested a special skin graft called X A-DERM™ mADM in 16 people who had Mohs surgery to remove skin cancers like basal cell carcinoma or squamous cell carcinoma. The graft has a micro-textured surface designed to help the wound heal faster and leave a better scar. Resea…
Sponsor: McGuire Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Double-Drug attack shows promise for tough head and neck cancers
Disease control CompletedThis study tested whether combining two FDA-approved cancer drugs, cetuximab and nivolumab, could help people with advanced head and neck cancer that has returned or spread. A total of 95 participants received the drug combination to find the best dose and see if it improves surv…
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy aims to cut side effects in head and neck cancer
Disease control CompletedThis study tested a three-step treatment for head and neck cancer that uses chemotherapy before surgery, then adjusts further treatment based on risk. The goal was to see if this personalized approach could reduce side effects while still controlling the cancer. 40 adults with a …
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immunotherapy drug shows promise in preventing High-Risk skin cancer recurrence
Disease control CompletedThis study tested whether the immunotherapy drug pembrolizumab (Keytruda) could help prevent skin cancer from returning in people with high-risk locally advanced squamous cell carcinoma who had already undergone surgery and radiation. About 450 participants were randomly assigned…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental drug rigosertib tested against aggressive skin cancer in rare disease patients
Disease control CompletedThis small early-phase trial tested an experimental drug called rigosertib in just 2 people with a rare blistering skin disease (recessive dystrophic epidermolysis bullosa) who also had advanced skin cancer. The goal was to see if the drug could shrink tumors and whether it was s…
Phase 1/2 • Sponsor: Prof. Johann Bauer • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New radiation zaps skin cancer without surgery
Disease control CompletedThis study tested a new device that delivers targeted radiation to early-stage basal and squamous cell skin cancers. Thirty-six people aged 60 and older received treatment, and researchers tracked how well the cancer was controlled, cosmetic results, and quality of life. The goal…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Switching transplant drug may cut skin cancer risk
Disease control CompletedThis study looked at kidney transplant patients who already had one skin cancer. It compared switching their anti-rejection medicine to rapamycin versus staying on standard drugs. The goal was to see if rapamycin could prevent new skin cancers over two years while keeping the tra…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Heart transplant drug may also fight skin cancer
Disease control CompletedThis study tested whether the drug everolimus can reduce new skin cancers in heart transplant patients who already had skin cancer. 175 participants received either everolimus or standard immunosuppressants. The goal was to see if everolimus lowers the number of new skin tumors n…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Experimental combo targets Hard-to-Treat head and neck cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs — IRX-2 and durvalumab — in 19 people with advanced head and neck cancer that could not be cured by standard treatments. The goal was to see if the combination was safe and could boost the immune response inside tumors. The…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Tiny radioactive seeds tested again for returning cancers
Disease control CompletedThis study tested whether a second round of treatment with tiny radioactive seeds (DaRT) could safely shrink or control skin, mouth, or soft tissue cancers that came back after the first treatment. Only 2 people took part, and researchers measured tumor response and side effects.…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Immunotherapy combo shows promise for inoperable esophageal cancer
Disease control CompletedThis Phase 2 trial tested whether adding the immunotherapy drug durvalumab to standard chemoradiation (FOLFOX and radiation) helps patients with unresectable esophageal cancer. 112 patients were randomly assigned to receive either chemoradiation alone or chemoradiation plus durva…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Smarter radiation dosing aims to cut side effects for head and neck cancer patients
Disease control CompletedThis study tested a new way of giving radiation to people with head and neck cancer. The goal was to lower the radiation dose to healthy neck areas to reduce side effects like trouble eating, while still keeping the cancer from coming back. About 300 patients took part, and the r…
Phase 3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a vaccine stop head and neck cancer from coming back?
Disease control CompletedThis study tested a vaccine called PepCan in 17 people who had head and neck cancer and were in remission. The goal was to see if the vaccine is safe and can reduce the chance of the cancer returning. Participants received seven injections of either PepCan or a placebo over about…
Phase 1/2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Immunotherapy boosts standard treatment for head and neck cancer in early trial
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation is safe and effective for people with advanced head and neck cancer. 59 participants received pembrolizumab before, during, and after their regular treatment. The goal was…
Phase 1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental vaccines show promise against HPV-Driven cancers
Disease control CompletedThis completed phase I/II trial tested two experimental vaccines, HB-201 and HB-202, in 198 people with HPV 16+ cancers. The goal was to find a safe dose and see if the vaccines could shrink tumors. Participants received the vaccines alone or with standard treatments like pembrol…
Phase 1/2 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated Jun 26, 2026 17:14 UTC
-
Can a glowing light reveal hidden mouth lesions?
Diagnosis CompletedResearchers are testing whether a handheld device that shines a special light on the inside of the mouth can help clinicians spot suspicious areas that might be precancerous or cancerous. The study will have three dentists with different levels of experience examine 200 adults, i…
Sponsor: Federico II University • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
A simple dye might replace radioactive tracers in cancer staging
Diagnosis CompletedThis trial tests whether indocyanine green, a dye injected before surgery, can find sentinel lymph nodes as reliably as the standard technetium-99 radioactive tracer. About 744 adults with various cancers will receive both agents, and surgeons will compare detection rates using a…
Phase 3 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Blood test spots hidden cancer after surgery in HPV head & neck patients
Diagnosis CompletedThis study tested a new blood test (liquid biopsy) to see if it could find any cancer left behind after surgery in 103 people with HPV-related head and neck cancer. The goal was to catch remaining disease early, which could help doctors decide if more treatment is needed. The tes…
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Could a natural compound help prevent cancer in a rare disease?
Prevention CompletedThis study tested whether quercetin, a natural substance found in some foods, could help prevent a type of mouth cancer in people with Fanconi anemia, a rare genetic condition that raises cancer risk. 48 participants took quercetin to see if it reduced certain cell changes linked…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Could a common pain cream help stop skin cancer before it starts?
Prevention CompletedThis study tested whether a daily application of diclofenac gel, a common anti-inflammatory drug, can reverse certain biomarkers in the skin that are linked to non-melanoma skin cancer. Twenty-four adults at risk for skin cancer applied the gel for 30 days, and researchers took s…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
DNA risk report may nudge people to shield from sun
Prevention CompletedThis study looked at whether giving people personalized information about their genetic risk for melanoma could encourage them to protect themselves from the sun. Over 2,000 adults received either standard sun safety tips or tailored advice based on their DNA. Researchers then tr…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC
-
New combo could delay painful mouth sores in cancer radiation
Symptom relief CompletedThis study tested whether adding thalidomide to glutamine can delay the onset of severe mouth sores caused by radiation therapy. 138 oral cancer patients were randomly assigned to receive either the combination or glutamine alone during their radiation treatment. The main goal wa…
Phase 3 • Sponsor: Air Force Military Medical University, China • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Could an antidepressant ease cancer treatment pain? new study investigates
Symptom relief CompletedThis phase 2 trial tested whether adding venlafaxine (an antidepressant) to a standard pain regimen of gabapentin, methadone, and oxycodone could better control pain in 62 people with head and neck cancer undergoing chemoradiation. The study measured pain scores and side effects …
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Snap and measure: new photo method tracks nose shape after skin cancer surgery
Knowledge-focused CompletedThis study tested a simple photo-based method to measure changes in nose shape and size after skin cancer surgery. Researchers took before-and-after photos of 68 patients who had surgery for common skin cancers. The goal was to see if this photographic approach could be a reliabl…
Sponsor: NHS Grampian • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Smoking and drinking leave genetic marks in mouth cells that may lead to cancer
Knowledge-focused CompletedThis study looked at 100 healthy adults to see how tobacco and alcohol use cause genetic changes in cells lining the mouth. Researchers collected cheek cells using a gentle brush and searched for mutations linked to oral cancer. The goal was to understand how these substances mig…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study explores what matters most to patients with high-risk head and neck skin cancer
Knowledge-focused CompletedThis study looked at how 78 patients with high-risk skin cancer on the head or neck felt about their treatment decisions, quality of life, and satisfaction with care. Researchers used standard questionnaires to measure these factors at two points: right after a team of doctors di…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Does waiting longer for surgery after chemoradiation improve esophageal cancer outcomes?
Knowledge-focused CompletedThis study looked at whether waiting 10-12 weeks instead of the usual 4-6 weeks after chemoradiation before surgery helps patients with esophageal or gastric cardia cancer. 202 participants were randomly assigned to one of the two timing groups. The goal was to see if a longer de…
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:40 UTC